Strategic Partnerships Breakthrough T1D has notable partnerships with Bayer, Encellin, IQVIA, and Greenstone Biosciences, indicating openness to collaboration on clinical trials, AI-enabled tools, and biologic research. This suggests sales opportunities in providing data analytics, trial management, and AI-enabled patient care solutions that can align with partner initiatives.

Philanthropic Funding With a high revenue range and active fundraising focus, there is appetite for sponsor packages, grant management platforms, and donor engagement tools. Propose solutions that streamline giving campaigns, impact reporting, and donor CRM integration to support expanded fundraising and program scalability.

Clinical Trial Support Recent news highlights involvement in phase 3 trials and multiple clinical initiatives related to kidney and heart disease in T1D. This creates demand for study operations software, data capture, regulatory documentation, and site coordination services to accelerate trial timelines.

Global Outreach Participation in India’s Type 1 Diabetes ecosystem and international summits signals a global expansion mindset. There are opportunities to offer multilingual content tools, region-specific fundraising campaigns, and international compliance capabilities to support cross-border programs.

Technology Enablement A tech stack spanning Tableau, Kubernetes, SharePoint, WordPress, and Adobe Experience Cloud indicates mature digital marketing and data needs. Position services around integrated dashboards, marketing automation, and scalable cloud-ready solutions that enhance donor engagement and program reporting.